Brande Yaist is the senior director of the Center of Expertise in Global Patient Outcomes and Real World Evidence (GPORWE) at Eli Lilly and Company. She leads and develops the research, talent and capabilities needed to provide scientific services/expertise and support across an array of core Health Economics & Outcomes Research (HEOR). Her 18 years’ experience at Lilly includes oversight and monitoring of early and late phase clinical trials, supervision, medical planning for compounds marketed in the U.S. and strategy and implementation for Risk Evaluation and Mitigation Strategies (REMS) and risk minimization plans globally.
Yaist led several projects as a Lean Six Sigma Black Belt, affecting areas of clinical development, regulatory affairs and global patient safety. Prior to her career at Lilly, she was a clinical research coordinator at Siteman Cancer Center in St. Louis. Yaist received her bachelor’s degree in nuclear medicine technology from St. Louis University and a Master of Health Science degree from Washington University in St. Louis.